Global Safety Lancets Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Safety Lancets Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Safety Lancets Market Size Growth Rate by Type
  • 1.4.2 Needle
  • 1.4.3 Blade
• 1.3 Market by Application
  • 1.3.1 Global Safety Lancets Market Size Growth Rate by Application
  • 1.3.2 Hospital and Clinics
  • 1.3.3 Diagnostic Centers
  • 1.3.4 Home Diagnostics
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Safety Lancets Sales Estimates and Forecasts 2016-2027
• 2.2 Global Safety Lancets Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Safety Lancets Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Safety Lancets Regions by Sales
  • 2.4.1 Global Top Safety Lancets Regions by Sales (2016-2021)
  • 2.4.2 Global Top Safety Lancets Regions by Sales (2022-2027)
• 2.5 Global Top Safety Lancets Regions by Revenue
  • 2.5.1 Global Top Safety Lancets Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Safety Lancets Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Safety Lancets Sales by Manufacturers
  • 3.1.1 Global Top Safety Lancets Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Safety Lancets Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Safety Lancets Sales in 2020
• 3.2 Global Safety Lancets Revenue by Manufacturers
  • 3.2.1 Global Top Safety Lancets Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Safety Lancets Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Safety Lancets Revenue in 2020
• 3.3 Global Safety Lancets Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Safety Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Safety Lancets Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Safety Lancets Sales by Type
  • 4.1.1 Global Safety Lancets Historical Sales by Type (2016-2021)
  • 4.1.2 Global Safety Lancets Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Safety Lancets Sales Market Share by Type (2016-2027)
• 4.2 Global Safety Lancets Revenue by Type
  • 4.2.1 Global Safety Lancets Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Safety Lancets Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Safety Lancets Revenue Market Share by Type (2016-2027)
• 4.3 Global Safety Lancets Price by Type
  • 4.3.1 Global Safety Lancets Price by Type (2016-2021)
  • 4.3.2 Global Safety Lancets Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Safety Lancets Sales by Application
  • 5.1.1 Global Safety Lancets Historical Sales by Application (2016-2021)
  • 5.1.2 Global Safety Lancets Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Safety Lancets Sales Market Share by Application (2016-2027)
• 5.2 Global Safety Lancets Revenue by Application
  • 5.2.1 Global Safety Lancets Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Safety Lancets Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Safety Lancets Revenue Market Share by Application (2016-2027)
• 5.3 Global Safety Lancets Price by Application
  • 5.3.1 Global Safety Lancets Price by Application (2016-2021)
  • 5.3.2 Global Safety Lancets Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Safety Lancets Market Size by Type
  • 6.1.1 North America Safety Lancets Sales by Type (2016-2027)
  • 6.1.2 North America Safety Lancets Revenue by Type (2016-2027)
• 6.2 North America Safety Lancets Market Size by Application
  • 6.2.1 North America Safety Lancets Sales by Application (2016-2027)
  • 6.2.2 North America Safety Lancets Revenue by Application (2016-2027)
• 6.3 North America Safety Lancets Market Size by Country
  • 6.3.1 North America Safety Lancets Sales by Country (2016-2027)
  • 6.3.2 North America Safety Lancets Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Safety Lancets Market Size by Type
  • 7.1.1 Europe Safety Lancets Sales by Type (2017-2027)
  • 7.1.2 Europe Safety Lancets Revenue by Type (2017-2027)
• 7.2 Europe Safety Lancets Market Size by Application
  • 7.2.1 Europe Safety Lancets Sales by Application (2017-2027)
  • 7.2.2 Europe Safety Lancets Revenue by Application (2017-2027)
• 7.3 Europe Safety Lancets Market Size by Country
  • 7.3.1 Europe Safety Lancets Sales by Country (2017-2027)
  • 7.3.2 Europe Safety Lancets Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Safety Lancets Market Size by Type
  • 8.1.1 Asia Pacific Safety Lancets Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Safety Lancets Revenue by Type (2018-2027)
• 8.2 Asia Pacific Safety Lancets Market Size by Application
  • 8.2.1 Asia Pacific Safety Lancets Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Safety Lancets Revenue by Application (2018-2027)
• 8.3 Asia Pacific Safety Lancets Market Size by Region
  • 8.3.1 Asia Pacific Safety Lancets Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Safety Lancets Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Safety Lancets Market Size by Type
  • 9.1.1 Latin America Safety Lancets Sales by Type (2019-2027)
  • 9.1.2 Latin America Safety Lancets Revenue by Type (2019-2027)
• 9.2 Latin America Safety Lancets Market Size by Application
  • 9.2.1 Latin America Safety Lancets Sales by Application (2019-2027)
  • 9.2.2 Latin America Safety Lancets Revenue by Application (2019-2027)
• 9.3 Latin America Safety Lancets Market Size by Country
  • 9.3.1 Latin America Safety Lancets Sales by Country (2019-2027)
  • 9.3.2 Latin America Safety Lancets Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Safety Lancets Market Size by Type
  • 6.1.1 Middle East and Africa Safety Lancets Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Safety Lancets Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Safety Lancets Market Size by Application
  • 6.2.1 Middle East and Africa Safety Lancets Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Safety Lancets Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Safety Lancets Market Size by Country
  • 6.3.1 Middle East and Africa Safety Lancets Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Safety Lancets Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 UAE

11 Company Profiles

• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Safety Lancets Product Description
  • 11.1.5 Roche Related Developments
• 11.2 BD
  • 11.2.1 BD Corporation Information
  • 11.2.2 BD Overview
  • 11.2.3 BD Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 BD Safety Lancets Product Description
  • 11.2.5 BD Related Developments
• 11.3 Bayer
  • 11.3.1 Bayer Corporation Information
  • 11.3.2 Bayer Overview
  • 11.3.3 Bayer Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Bayer Safety Lancets Product Description
  • 11.3.5 Bayer Related Developments
• 11.4 Lifescan
  • 11.4.1 Lifescan Corporation Information
  • 11.4.2 Lifescan Overview
  • 11.4.3 Lifescan Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Lifescan Safety Lancets Product Description
  • 11.4.5 Lifescan Related Developments
• 11.5 B. Braun
  • 11.5.1 B. Braun Corporation Information
  • 11.5.2 B. Braun Overview
  • 11.5.3 B. Braun Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 B. Braun Safety Lancets Product Description
  • 11.5.5 B. Braun Related Developments
• 11.6 Terumo
  • 11.6.1 Terumo Corporation Information
  • 11.6.2 Terumo Overview
  • 11.6.3 Terumo Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Terumo Safety Lancets Product Description
  • 11.6.5 Terumo Related Developments
• 11.7 Nipro
  • 11.7.1 Nipro Corporation Information
  • 11.7.2 Nipro Overview
  • 11.7.3 Nipro Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Nipro Safety Lancets Product Description
  • 11.7.5 Nipro Related Developments
• 11.8 Sarstedt
  • 11.8.1 Sarstedt Corporation Information
  • 11.8.2 Sarstedt Overview
  • 11.8.3 Sarstedt Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Sarstedt Safety Lancets Product Description
  • 11.8.5 Sarstedt Related Developments
• 11.9 ARKRAY
  • 11.9.1 ARKRAY Corporation Information
  • 11.9.2 ARKRAY Overview
  • 11.9.3 ARKRAY Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 ARKRAY Safety Lancets Product Description
  • 11.9.5 ARKRAY Related Developments
• 11.10 Smiths Medical
  • 11.10.1 Smiths Medical Corporation Information
  • 11.10.2 Smiths Medical Overview
  • 11.10.3 Smiths Medical Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Smiths Medical Safety Lancets Product Description
  • 11.10.5 Smiths Medical Related Developments
• 11.1 Roche
  • 11.1.1 Roche Corporation Information
  • 11.1.2 Roche Overview
  • 11.1.3 Roche Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 Roche Safety Lancets Product Description
  • 11.1.5 Roche Related Developments
• 11.12 HemoCue
  • 11.12.1 HemoCue Corporation Information
  • 11.12.2 HemoCue Overview
  • 11.12.3 HemoCue Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 HemoCue Product Description
  • 11.12.5 HemoCue Related Developments
• 11.13 Greiner Bio One
  • 11.13.1 Greiner Bio One Corporation Information
  • 11.13.2 Greiner Bio One Overview
  • 11.13.3 Greiner Bio One Safety Lancets Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Greiner Bio One Product Description
  • 11.13.5 Greiner Bio One Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Safety Lancets Value Chain Analysis
• 12.2 Safety Lancets Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Safety Lancets Production Mode & Process
• 12.4 Safety Lancets Sales and Marketing
  • 12.4.1 Safety Lancets Sales Channels
  • 12.4.2 Safety Lancets Distributors
• 12.5 Safety Lancets Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Safety Lancets Industry Trends
• 13.2 Safety Lancets Market Drivers
• 13.3 Safety Lancets Market Challenges
• 13.4 Safety Lancets Market Restraints

14 Key Findings in The Global Safety Lancets Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details